Sales decline 10.76% to Rs 17.09 crore
Net profit of Sandu Pharmaceuticals rose 6.67% to Rs 0.48 crore in the quarter ended December 2022 as against Rs 0.45 crore during the previous quarter ended December 2021. Sales declined 10.76% to Rs 17.09 crore in the quarter ended December 2022 as against Rs 19.15 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales17.0919.15 -11 OPM %4.804.02 -PBDT0.830.77 8 PBT0.700.64 9 NP0.480.45 7Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
